17.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TVTX Giù?
Forum
Previsione
Frazionamento azionario
Travere Therapeutics Inc Azioni (TVTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
40.03%
114.45
|
81.73 | 62.90 | 54.12 | 41.37 |
Cost Of Revenue |
67.49%
1.521
|
4.679 | 1.626 | 2.061 | 1.504 |
Gross Profit |
46.56%
112.93
|
77.05 | 61.27 | 52.05 | 39.87 |
|
4.89%
125.58
|
119.73 | 117.42 | 119.76 | 179.11 |
Benefits Costs and Expenses |
3.47%
127.18
|
122.92 | 117.73 | 123.68 | 177.14 |
Costs And Expenses |
2.16%
127.10
|
124.41 | 119.05 | 121.82 | 180.61 |
Operating Income/Loss |
70.36%
-12.65
|
-42.67 | -56.15 | -67.70 | -139.24 |
Nonoperating Income/Loss |
105.72%
-0.085
|
1.487 | 1.313 | -1.863 | 3.47 |
Income/Loss From Continuing Operations Before Tax |
69.08%
-12.73
|
-41.19 | -54.84 | -69.57 | -135.77 |
Income Tax Expense/Benefit |
48.72%
0.02
|
0.039 | -0.084 | 0.085 | 0.191 |
Income/Loss From Continuing Operations After Tax |
69.06%
-12.76
|
-41.23 | -54.75 | -69.65 | -135.96 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | -0.059 | -0.757 | -0.103 |
|
69.06%
-12.76
|
-41.23 | -54.81 | -70.41 | -136.06 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.67%
88.95
|
88.36 | 77.78 | 77.50 | 77.14 |
Diluted Average Shares |
0.67%
88.95
|
88.36 | 77.78 | 77.50 | 77.14 |
Basic Earnings Per Share |
70.21%
-0.14
|
-0.47 | -0.70 | -0.91 | -1.76 |
Diluted Earnings Per Share |
70.21%
-0.14
|
-0.47 | -0.70 | -0.91 | -1.76 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):